Pulmonary delivery of remdesivir and dexamethasone encapsulated nanostructured lipid carriers for enhanced inflammatory suppression in lung

Paxlovid-Tacrolimus Drug–Drug Interaction in a 23-Year-Old Female Kidney Transplant Patient with COVID-19

(2022) Noa Berar Yanay et al.   CLINICAL DRUG INVESTIGATION

Lipopolysaccharide-induced murine lung injury results in long-term pulmonary changes and downregulation of angiogenic pathways

(2022) S. T. Tsikis et al.   Scientific Reports

Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation

(2022) Ameeduzzafar Zafar et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Dexamethasone: Therapeutic potential, risks, and future projection during COVID-19 pandemic

(2021) Sobia Noreen et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor

(2021) Rita Humeniuk et al.   CLINICAL PHARMACOKINETICS

ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential

(2021) Subrata Deb et al.   Pharmaceuticals

Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit

(2020) Duxin Sun   AAPS Journal

The cytokine storm and COVID‐19

(2020) Biying Hu et al.   JOURNAL OF MEDICAL VIROLOGY

Advantages of the Parent Nucleoside GS-441524 over Remdesivir for Covid-19 Treatment

(2020) Victoria C. Yan et al.   ACS Medicinal Chemistry Letters

Pulmonary administration of remdesivir in the treatment of COVID-19

(2020) Henrik Berg Rasmussen et al.   AAPS Journal

Animal models for COVID-19

(2020) César Muñoz-Fontela et al.   NATURE

Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease

(2019) Matt Shirley   DRUGS

Effects of glycyrrhizin on lipopolysaccharide-induced acute lung injury in a mouse model

(2019) Song Am Lee et al.   Journal of Thoracic Disease

Dexamethasone Degradation in Aqueous Medium and Implications for Correction of In Vitro Release from Sustained Release Delivery Systems

(2019) Brock Matter et al.   AAPS PHARMSCITECH

Lipid-based pulmonary delivery system: a review and future considerations of formulation strategies and limitations

(2018) Cheng Loong Ngan et al.   Drug Delivery and Translational Research

Development of Dual Drug Loaded Nanosized Liposomal Formulation by A Reengineered Ethanolic Injection Method and Its Pre-Clinical Pharmacokinetic Studies

(2018) Muhammad Sarfraz et al.   Pharmaceutics

Anti-ICAM-1 antibody-modified nanostructured lipid carriers: a pulmonary vascular endothelium-targeted device for acute lung injury therapy

(2018) Shujuan Li et al.   JOURNAL OF NANOBIOTECHNOLOGY

In vitro cytotoxicity evaluation of resveratrol-loaded nanoparticles: Focus on the challenges of in vitro methodologies

(2017) V. Rocha et al.   FOOD AND CHEMICAL TOXICOLOGY

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

(2017) Timothy P. Sheahan et al.   Science Translational Medicine

Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: A review of the state of the art

(2013) S. Weber et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Liposome: classification, preparation, and applications

(2013) Abolfazl Akbarzadeh et al.   Nanoscale Research Letters

Wound Repair and Regeneration

(2012) J.M. Reinke et al.   EUROPEAN SURGICAL RESEARCH

Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers

(2010) Ram R. Patlolla et al.   JOURNAL OF CONTROLLED RELEASE